Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
BDJ Open
|
August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database
Cathy Chen, Manish Saxena, Christian von Heymann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
June 17, 2024
Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program
Martin Unverdorben, Paolo Colonna, James Jin, et al.
Journal of Clinical Medicine
|
February 6, 2021
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program
Raffaele De Caterina, Young-Hoon Kim, Yukihiro Koretsune, et al.
The American Journal of Cardiology
|
January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF Trial
Christian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Thrombosis Journal
|
December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study
Christian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Indian Heart Journal
|
October 30, 2012
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events
Matthias Leschke, Vo Thanh Nhan, Matthias Waliszewski, et al.
Journal of the Chinese Medical Association : JCMA
|
March 20, 2021
Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program
Tze-Fan Chao, Keun-Sik Hong, Byung-Chul Lee, et al.
The American Journal of Cardiology
|
December 17, 2025
Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
Johny Nicolas, George Dangas, Amanda Borrow, et al.
The American Journal of Cardiology
|
October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial
Christian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Journal of Clinical Medicine
|
November 27, 2021
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice
Eue-Keun Choi, Wei-Shiang Lin, Gyo-Seung Hwang, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
BDJ Open
|
August 14, 2023
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database
Cathy Chen, Manish Saxena, Christian von Heymann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
June 17, 2024
Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program
Martin Unverdorben, Paolo Colonna, James Jin, et al.
Journal of Clinical Medicine
|
February 6, 2021
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program
Raffaele De Caterina, Young-Hoon Kim, Yukihiro Koretsune, et al.
The American Journal of Cardiology
|
January 1, 2026
Patient-Reported Outcomes Using Win Ratio Analysis: A Post Hoc Analysis From The Randomized ENVISAGE-TAVI AF Trial
Christian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Thrombosis Journal
|
December 15, 2023
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study
Christian von Heymann, Martin Unverdorben, Paolo Colonna, et al.
Indian Heart Journal
|
October 30, 2012
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events
Matthias Leschke, Vo Thanh Nhan, Matthias Waliszewski, et al.
Journal of the Chinese Medical Association : JCMA
|
March 20, 2021
Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program
Tze-Fan Chao, Keun-Sik Hong, Byung-Chul Lee, et al.
The American Journal of Cardiology
|
December 17, 2025
Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
Johny Nicolas, George Dangas, Amanda Borrow, et al.
The American Journal of Cardiology
|
October 17, 2023
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial
Christian Hengstenberg, Nicolas M Van Mieghem, Rosa Wang, et al.
Journal of Clinical Medicine
|
November 27, 2021
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice
Eue-Keun Choi, Wei-Shiang Lin, Gyo-Seung Hwang, et al.
Page
of 8